Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054953A1 NOVEL pgsA
11/29/2000EP1054950A2 Hiv chemokines
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054903A1 Fishboy, a g-protein coupled receptor
11/29/2000EP1054902A1 Agents for the prevention of damages caused by stress conditions
11/29/2000EP1054901A2 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions
11/29/2000EP1054900A1 Therapeutic uses of keratinocyte growth factor-2
11/29/2000EP1054899A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON $g(b)-CATENIN, AND THE PRODUCTION AND USE THEREOF
11/29/2000EP1054898A1 Neuroprotective peptides and uses thereof
11/29/2000EP1054896A1 ANALGESIC PEPTIDES FROM VENOM OF $i(GRAMMOSTOLA SPATULATA) AND USE THEREOF
11/29/2000EP1054894A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
11/29/2000EP1054892A1 Azole peptidomimetics as thrombin receptor antagonists
11/29/2000EP1054880A1 TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054692A2 Antibodies against human cd40
11/29/2000EP1054691A1 Skin care compositions
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP1054686A1 Pharmaceutical formulation of a didemnin compound
11/29/2000EP1054685A1 Liquid crystal forms of cyclosporin
11/29/2000EP1054684A1 Method of promoting neuronal cell proliferation and differentiation
11/29/2000EP1054683A1 Modified heat shock protein-antigenic peptide complex
11/29/2000EP1054677A1 Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
11/29/2000EP1054675A1 Regulation of estrus and ovulation in gilts
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000EP1054591A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
11/29/2000EP0991770B1 Prostate cancer gene
11/29/2000EP0862453A4 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
11/29/2000EP0784753B1 Axial flow valve system in combination with a linera compressor
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000EP0629133B1 Peptide-metal ion pharmaceutical applications
11/29/2000EP0586592B1 Insulin and amylin containing composition for the treatment of insulin deficient mammals
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1275132A Treatmet of obesity
11/29/2000CN1275131A Human lysophospholipase gene (CBFBLH05)
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275083A Alpha-glucosidase inhibitor
11/29/2000CN1275080A Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus
11/29/2000CN1275050A Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
11/29/2000CN1274729A New tumor necrosin mutein and its preparation and application
11/29/2000CN1274606A Oral liquid capable of increasing hemogram, strengthening immunity and suppressing tumor during radiotherapy and chemtherapy of cancer
11/29/2000CN1274605A Oral insulin granule and its preparation
11/29/2000CN1274601A Immunity-strengthening and infection-preventing medicine
11/29/2000CN1058993C Prepn. and use of molecular chimera for treatment of cancer
11/29/2000CN1058991C Hematopoietic facilitatory cells
11/28/2000US6153740 Polynucleotide sequence coding a transport polypeptide; for the treatment of human tumors and viral diseases; antitumor agents
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153738 Having 6-12 amino acids, preferably including one or more d-tryptophan or d-leucine residues; anticonvulsants, neuroprotective agents
11/28/2000US6153731 Dehydrodidemnin B
11/28/2000US6153730 Detoxification by heparin binding, heparin neutralization, endotoxin binding, endotoxin neutralization or bactericidal activity
11/28/2000US6153729 A polypeptide for drug delivering a variety of therapeutic and diagnostic agents, such as transcription regulatory factors of the cell
11/28/2000US6153632 Method and composition for the treatment of diabetes
11/28/2000US6153613 2,3-diketopiperazine derivatives or their salts
11/28/2000US6153600 Administering, in vivo, at or around the site of the solid tumor, a nucleic acid which encodes an ip-10 polypeptide, for inhibiting a solid tumor in a mammal
11/28/2000US6153599 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
11/28/2000US6153597 For gene therapy such as in vitro, ex vivo and/or in vivo transfer of genetic material
11/28/2000US6153595 Composition and method for treatment of CMV infections
11/28/2000US6153593 Laminin 5 and the formation of basement membrane structure
11/28/2000US6153592 Protein or peptidic therapeutic agent in combination with protecting agent comprising protein, purified natural protein, molecular weight fractionated protein, or partially hydrolyzed protein to prevent enzymatic inactivation
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis
11/28/2000US6153590 Biologically active peptides and compositions, their use
11/28/2000US6153589 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents
11/28/2000US6153588 Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-4-yl)butanoyl)-N-ethylglycyl] aspartyl]-L-β-cyclohexyl alanine amide
11/28/2000US6153587 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
11/28/2000US6153586 Methods for treating prostate cancer with LHRH-R antagonists
11/28/2000US6153585 Arylsulfonanilide derivatives
11/28/2000US6153584 Administering an amount of bactericidal permeability-increasing protein (bpi) protein product effective to alleviate the bpi deficiency
11/28/2000US6153583 OP-3 induced morphogenesis
11/28/2000US6153581 Drug for recovering renal function
11/28/2000US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation
11/28/2000US6153427 Erythropoietin-inducible, erythroid-specific DNA construct
11/28/2000US6153418 Enzymatic polypeptide for use in preparation of animal feeds
11/28/2000US6153408 Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
11/28/2000US6153407 Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
11/28/2000US6153405 Nucleic acid which encodes a leader sequence from nisin and/or subtilin and a lantibiotic; for recombinant production of antibiotics
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153397 Protein having defined amino acid and nucleotide sequences; drug screening of parasiticides; vaccines; veterinary medicine
11/28/2000US6153396 Drug screening by adding compound to mixture of chaperone and pilus subunit and determining the change in binding; bactericides for urinary tract infections
11/28/2000US6153391 Contacting p53 and oncoprotein with a peptide fragment or analogue including a defined amino acid sequence or an organic molecule having three-dimensional structure of that amino acid sequence; interferes with binding
11/28/2000US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis
11/28/2000US6153375 Making combinatorial libraries by using specific solid support and then repeatedly adding reagent, recording identify of zones, and subdividing batches
11/28/2000US6153251 Nutrition-enriched composition for feed
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153211 Mixing biologically active drug with a macromer, polymerizing the mixture to form particles, administering the particles for therapeutic treatment
11/28/2000US6153203 Immunological tolerance-inducing agent
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153195 Method of delivering drugs to cells specific for an HL-60 lectin
11/28/2000US6153194 Borrelia burgdorferi outer membrane proteins
11/28/2000US6153191 Giardia treatment and antibody
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000US6153188 A recombinant human iduronate 2-sulfatase (ids) which is highly glycosylated than the naturally occurring enzyme isolated from human tissue and wherein recombinant iduronate 2-sulfatase is produced in chinese hamster overy cells
11/28/2000US6153187 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000US6153184 Contacting, by ductal cannulation, the ductal epithelium of the exocrine gland with a cytolytic virus to destroy less than all of the ductal epithelium so as to inhibit formation of cancer of ductal epithelial origin
11/28/2000US6153183 A modified human interleukin-3 polypeptide, comprises the replacement of 6 to about 44 residues at positions 17-118 of native interleukin-3 by other amino acids with the proviso that asparagine at position 101 and lysine at position 116
1 ... 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 ... 3163